Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Neurobiology of Aging|January 5, 2010
Age-related alterations affect the susceptibility of mice to prion infectionDana Avrahami, Ruth GabizonHandbook of Clinical Neurology|June 12, 2018
Identifying therapeutic targets and treatments in model systemsCorinne Lasmézas, Ruth GabizonFEBS Letters|October 22, 2002
Doppel and PrP(C) do not share the same membrane microenvironmentYuval Shaked, Nuha Hijazi, Ruth GabizonJournal of Neurochemistry|July 2, 2002
The binding of prion proteins to serum components is affected by detergent extraction conditionsYuval Shaked, Roni Engelstein, Ruth GabizonNeurobiology of Aging|August 31, 2020
Delay of gCJD aggravation in sick TgMHu2ME199K mice by combining NPC transplantation and Nano-PSO administrationKati Frid, Orli Binyamin, Areen Usman, et al.The Journal of Biological Chemistry|January 26, 2005
PrPSc incorporation to cells requires endogenous glycosaminoglycan expressionNuha Hijazi, Zehavit Kariv-Inbal, Maria Gasset, et al.Neurobiology of Aging|December 7, 2021
Comparing anti-aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob DiseaseOrli Binyamin, Kati Frid, Guy Keller, et al.Plos One|January 28, 2009
Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversionGiorgio Colombo, Massimiliano Meli, Giulia Morra, et al.Neurobiology of Disease|November 14, 2018
Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment?Guy Keller, Orli Binyamin, Kati Frid, et al.Cellular and Molecular Neurobiology|March 20, 2008
Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation timeTehila Mayer-Sonnenfeld, Dana Avrahami, Yael Friedman-Levi, et al.Pageof 5